1. Home
  2. STOK vs TV Comparison

STOK vs TV Comparison

Compare STOK & TV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$30.65

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo Grupo Televisa S.A.

TV

Grupo Televisa S.A.

HOLD

Current Price

$2.72

Market Cap

1.5B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
STOK
TV
Founded
2014
1969
Country
United States
Mexico
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Broadcasting
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
2019
1993

Fundamental Metrics

Financial Performance
Metric
STOK
TV
Price
$30.65
$2.72
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
4
Target Price
$31.00
$4.93
AVG Volume (30 Days)
1.2M
1.4M
Earning Date
11-04-2025
10-23-2025
Dividend Yield
N/A
2.98%
EPS Growth
N/A
N/A
EPS
0.68
N/A
Revenue
$205,632,000.00
$3,246,959,081.00
Revenue This Year
$416.54
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$45.14
N/A
Revenue Growth
1128.17
N/A
52 Week Low
$5.35
$1.55
52 Week High
$38.69
$3.10

Technical Indicators

Market Signals
Indicator
STOK
TV
Relative Strength Index (RSI) 60.05 49.12
Support Level $28.51 $2.70
Resistance Level $29.38 $2.79
Average True Range (ATR) 1.99 0.12
MACD 0.55 -0.03
Stochastic Oscillator 93.67 12.79

Price Performance

Historical Comparison
STOK
TV

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

About TV Grupo Televisa S.A.

Televisa is one of the leading telecommunication firms in Mexico. Its cable arm, Izzi, holds networks that pass 20 million Mexican homes and provide broadband service to nearly 6 million customers. The firm is also one of the largest pay-television providers in Mexico, with 4 million customers. Televisa owns Sky Mexico, the country's only satellite-TV provider, serving about 5 million customers. After merging its traditional media business into Univision, Grupo Televisa owns a 43% stake in combined entity TelevisaUnivision. Grupo Televisa spun off several smaller businesses, including magazine publishing, three of Mexico's professional soccer teams, and Azteca Stadium in February 2024, under the name Ollamani.

Share on Social Networks: